GW Henssler & Associates Ltd. Cuts Position in Becton Dickinson and Co. (BDX)
GW Henssler & Associates Ltd. cut its stake in Becton Dickinson and Co. (NYSE:BDX) by 12.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,139 shares of the company’s stock after selling 4,940 shares during the period. GW Henssler & Associates Ltd.’s holdings in Becton Dickinson and were worth $6,129,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of the company. Iowa State Bank acquired a new stake in shares of Becton Dickinson and during the second quarter valued at $137,000. ClariVest Asset Management LLC acquired a new stake in shares of Becton Dickinson and during the second quarter valued at $170,000. Court Place Advisors LLC acquired a new stake in shares of Becton Dickinson and during the second quarter valued at $200,000. Cottage Street Advisors LLC acquired a new stake in shares of Becton Dickinson and during the second quarter valued at $204,000. Finally, Meeder Asset Management Inc. acquired a new stake in shares of Becton Dickinson and during the first quarter valued at $210,000. 81.96% of the stock is owned by institutional investors and hedge funds.
Shares of Becton Dickinson and Co. (NYSE:BDX) traded down 0.54% during mid-day trading on Friday, hitting $171.93. The stock had a trading volume of 866,532 shares. Becton Dickinson and Co. has a 52-week low of $129.50 and a 52-week high of $181.76. The stock has a 50 day moving average price of $176.46 and a 200-day moving average price of $169.48. The company has a market cap of $36.61 billion, a PE ratio of 32.81 and a beta of 0.93.
Becton Dickinson and (NYSE:BDX) last announced its earnings results on Thursday, August 4th. The company reported $2.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.21 by $0.14. The firm earned $3.20 billion during the quarter, compared to analysts’ expectations of $3.21 billion. Becton Dickinson and had a return on equity of 24.26% and a net margin of 9.24%. The business’s revenue was up 2.5% on a year-over-year basis. During the same period in the prior year, the firm earned $2.05 EPS. On average, equities analysts expect that Becton Dickinson and Co. will post $8.56 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Friday, September 30th. Investors of record on Friday, September 9th were given a $0.66 dividend. The ex-dividend date was Wednesday, September 7th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 1.54%. Becton Dickinson and’s dividend payout ratio (DPR) is presently 50.19%.
Several equities research analysts have weighed in on BDX shares. Jefferies Group reissued a “buy” rating on shares of Becton Dickinson and in a report on Friday, August 5th. Bank of America Corp. restated a “buy” rating on shares of Becton Dickinson and in a research note on Tuesday, July 12th. Leerink Swann restated a “hold” rating on shares of Becton Dickinson and in a research note on Tuesday, August 9th. Zacks Investment Research cut Becton Dickinson and from a “buy” rating to a “hold” rating in a research note on Wednesday, July 13th. Finally, Cowen and Company restated an “outperform” rating and issued a $185.00 price objective on shares of Becton Dickinson and in a research note on Tuesday, August 16th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $170.82.
In other Becton Dickinson and news, insider Gary M. Cohen sold 29,367 shares of the stock in a transaction that occurred on Thursday, August 11th. The stock was sold at an average price of $176.81, for a total transaction of $5,192,379.27. Following the completion of the sale, the insider now directly owns 125,870 shares of the company’s stock, valued at approximately $22,255,074.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Linda M. Tharby sold 11,704 shares of the stock in a transaction that occurred on Tuesday, September 6th. The stock was sold at an average price of $177.27, for a total value of $2,074,768.08. Following the sale, the insider now directly owns 22,146 shares of the company’s stock, valued at $3,925,821.42. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.
About Becton Dickinson and
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton Dickinson and Co. (NYSE:BDX).
Receive News & Ratings for Becton Dickinson and Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co. and related companies with MarketBeat.com's FREE daily email newsletter.